Read + Share
Levy ME, Agopian A, Magnus M, Rawls A, et al. Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM
in the District of Columbia? J Acquir Immune Defic Syndr 2021;86:e80-e82.
PMID: 33148996
|
 |
|
Levy ME, Agopian A, Magnus M, Rawls A, et al. Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM
in the District of Columbia? J Acquir Immune Defic Syndr 2021;86:e80-e82.
PMID: 33148996
|
|
|
|